The Matt Garza sweepstakes finally ended on Monday, with the Texas Rangers emerging victorious in their long pursuit of the Chicago Cubs veteran hurler. In return for the 29-year-old right-hander, Chicago obtained three young players — third baseman Mike Olt, as well as pitchers Justin Grimm and C.J. Edwards — and one or two players to be named later (depending on who the first PTBNL is).
Major League Baseball suspended Ryan Braun for the remainder of the season on Monday for “violations of the Basic Agreement and its Joint Drug Prevention and Treatment Program,” according to a press release the league issued. The release also included a statement from Braun in which he admitted that he had “made some mistakes” and was “willing to accept the consequences of those actions.” The suspension for the remainder of the season amounts to a 65-game punishment.
A press release with statements from both MLB executives and Braun strongly suggests the suspension was the result of negotiations between the two sides. We also have this from Bill Shakin of the Los Angeles Times:
Hearing Braun approached MLB proactively, rather than being presented with a proposed suspension and starting to deal from there.
— Bill Shaikin (@BillShaikin) July 22, 2013
But before any such discussions took place, MLB and Braun likely had tentative game plans. MLB may have been planning to suspend Braun for much longer than 65 games. Braun undoubtedly was planning to appeal any such suspension. Braun gave up his appeal and agreed to serve the suspension immediately, likely in return for shorter suspension period.
That’s what we know or can reasonably infer from the information the league provided. But there are many questions we don’t have answers to; questions that will shape the remainder of the league’s Biogenesis investigation.
Ben and Sam interview former big-league outfielder Gabe Kapler about his respect for sabermetrics and the purpose advanced stats can serve for players.
Podcast (effectively-wild): Play in new window | Download
Subscribe: RSS
Episode 363
Dave Cameron is both (a) the managing editor of FanGraphs and (b) the guest on this particular edition of FanGraphs Audio — during which edition he discusses his recently completed trade-value series.
Don’t hesitate to direct pod-related correspondence to @cistulli on Twitter.
You can subscribe to the podcast via iTunes or other feeder things.
Audio after the jump. (Approximately 43 min play time.)
Podcast: Play in new window | Download
Subscribe: RSS
Well, the first shoe in the BioGenesis case has fallen. Faced with the possibility of having the issue continue to linger into 2014, Ryan Braun has agreed to a deal with MLB, and will be suspended for the rest of the 2013 season, which in the Brewers case, amounts to 65 games.
While Braun’s not going to enjoy being suspended, this is actually a pretty good resolution for the Brewers overall. Their 2013 season is obviously finished, and the marginal value of Braun’s contributions this year weren’t really going to matter to the organization. Without him in the line-up, they might even end up with a better draft pick than they would have otherwise in a year where the amateur talent is supposed to be pretty good.
More importantly, this should close the book on the BioGenesis case as far as Braun is concerned, which means that his 2014 status should no longer be in doubt. Braun basically is agreeing to serve a 65 game suspension in a season where those games are meaningless in order to avoid getting suspended in a year where any missed games might impact a pennant race.
For Braun’s own personal legacy and record, this is a blow, but for the Brewers, it’s hard to imagine a better outcome, given that MLB clearly wasn’t going to let this go. Yeah, it’s 65 games, but this is the equivalent of getting pinch hit for in a blow-out. The 2013 Brewers weren’t going anywhere with Ryan Braun, and so now, they put this behind them next spring and try to win with their best player able to spend the whole season on the active roster.
It will be interesting to see how many other players on non-contenders agree to similar deals, putting the appeals process aside and just agreeing to serve their suspensions in lost seasons. If I’m a non-contender and I’ve got a player linked to BioGenesis, I’m strongly urging them to do the same.
UPDATE: Matt Garza has officially been traded from the Cubs to the Rangers, reportedly in exchange for Mike Olt, C.J. Edwards, Justin Grimm, and a player to be named later. This post was originally published on Friday, July 19.
Matt Garza hasn’t been traded, yet, so Matt Garza hasn’t been traded to the Rangers, yet. In fact, a report circulated late Thursday night that the Rangers were examining their other options, backing away from the Garza pursuit. The price, they say, is a high one. But, Friday’s reports have made a Cubs/Rangers trade appear imminent, and as a matter of fact one could go down while I’m in the process of writing this post. That would be annoying for me but delightful for you. It’s a virtual certainty that the Cubs will deal Garza very soon, and the Rangers seem like far and away the most likely destination.
Joe Davidson says the Rangers and Cubs are reviewing the various medicals. If true, that implies this is at the later stages, and what’s unknown is what the Rangers would be giving up. It stands to reason Mike Olt would probably be involved, along with others, but I’ll leave prospect coverage to prospect coverers. Most important, here, is Garza — the free-agent-to-be — going to Texas, and what such a transaction might tell us about the way the Rangers view themselves.
On Saturday in DC, there was a showdown between the Dodgers and the Nationals, as two teams with high expectations looked to kick-start strong second halves. The Dodgers won 3-1, but that’s not important, for this. The matchup on the mound was Zack Greinke vs. Gio Gonzalez. In the top of the third, Greinke batted and led off with a first-pitch double to deep center. Mark Ellis, Yasiel Puig, and Adrian Gonzalez would leave him stranded. In the top of the fifth, Greinke batted again and drilled a second-pitch single up the middle. Around him, Tim Federowicz, Ellis, and Puig struck out swinging. That night, Hanley Ramirez led the Dodgers with three hits, and Greinke was alone in second with two.
By now you might’ve heard something about this. After reading that first paragraph, you’ve certainly heard something about this. Zack Greinke has been having a hell of a year at the plate. Obviously with pitchers batting the samples are always tiny, but that generally doesn’t stop pitchers from posting miserable offensive statistics. Greinke, at this writing, is batting .406. No other pitcher in baseball is batting at least .400. No other pitcher in baseball is batting at least .300. No other pitcher in baseball has a wRC+ in the triple digits.
Carlos Delgado’s official retirement in 2011 sort of slipped under the radar. It was understandable, since it came in April right after the beginning of the season. It was a bit unfortunate, though, because Delgado had an wonderful career. Yesterday at the Rogers Centre, the former Met and Marlin slugger was recognized by the team he was most closely associated with, the Blue Jays, during a ceremony in which he was inducted into the Jays’ “Level of Excellence.”
[It’s a tremendous name, isn’t it? I can imagine the brainstorming that went into it. Team President: “You need to come up with a name for our version of a Ring of Honor that is a bit different. Something like, ‘Level of Excellence,’ but, you know, better.” {President leaves rooms.} Marketing Person to others: “‘Level of Excellence’ okay with everyone?” {Others shrug in assent.}]
Delgado was outstanding, but he was no Hall of Famer. He move from catcher to first base early on, and even that position was a stretch, no matter how hard he tried. He was bad on the bases. But the guy could hit. From 1997 to 2004, he was one of the best hitters in the American League. His 148 wRC+ over that span was the equal of Alex Rodriguez and better than Edgar Martinez and Frank Thomas.
Last week, I went through the 50 best assets in baseball, as rated by overall trade value based on their performance, age, and contract status. Today, we finish up the Trade Value series with the five players farthest from making the list. This is the Anti-Trade Value list; the guys who would be nearly impossible to trade because of their outsized contracts and undersized performances.
The take home notion: Beware the aging slugger.
| 11:56 |
: If I was a jerk, I’d announce my arrival with the LOUDEST SOUND EFFECT EVER. I can totally gets dozens of people fired!
|
| 11:57 |
:
|
| 11:57 |
Man, how desperate are the giants if they are taking a chance on Francoeur? |
| 11:58 |
: It’s not really so bad as long as you’re using him as a role player. The risk, of course, is that he starts off with his usual good month with new team and tricks Giants into signing him
|
| 11:58 |
: Francoeur’s essentially a no money down credit card.
|
| 11:58 |
: Err no interest
|
